NET Clinical Trials

2 recruiting

NET Trials at a Glance

405 actively recruiting trials for net are listed on ClinicalTrialsFinder across 6 cities in 52 countries. The largest study group is Not Applicable with 150 trials, with the heaviest enrollment activity in Boston, Philadelphia, and New York. Lead sponsors running net studies include Centre Hospitalier Universitaire, Amiens, Anhui Medical University, and Children's Hospital of Fudan University.

Treatments under study

About NET Clinical Trials

Looking for clinical trials for NET? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new NET trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about NET clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 405 trials

Recruiting

Study of New Magnetic Resonance Imaging Methods of the Brain

HealthyHealthy VolunteerAdult+3 more
National Institute of Neurological Disorders and Stroke (NINDS)1,100 enrolled1 locationNCT00004577
Recruiting

Inherited Reproductive Disorders

InfertilityHypogonadismAmenorrhea+1 more
National Institute of Environmental Health Sciences (NIEHS)850 enrolled2 locationsNCT01500447
Recruiting

Vascular Disease Discovery Protocol

Vascular DysfunctionGenetic PredispositionGenetic Mutations
National Heart, Lung, and Blood Institute (NHLBI)1,000 enrolled1 locationNCT03538639
Recruiting
Not Applicable

Non-Invasive Monitoring Of Metabolite Levels Using Novel And Adapted MR Spectroscopy Techniques

Magnetic Resonance Spectroscopy
Insel Gruppe AG, University Hospital Bern100 enrolled1 locationNCT05165537
Recruiting
Phase 4

Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies

AntibioticsPeriodontal DiseasesPharmacokinetics
University of Geneva, Switzerland45 enrolled1 locationNCT04669717
Recruiting
Phase 3

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals240 enrolled65 locationsNCT06784752
Recruiting
Phase 1

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Solid TumorLymphomaGIST+5 more
ITM Solucin GmbH20 enrolled5 locationsNCT06441331
Recruiting

Turner Syndrome: Genetic Considerations

Genetic
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)500 enrolled1 locationNCT07502586
Recruiting
Phase 2Phase 3

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Symptomatic Genetic Dilated Cardiomyopathy
Kardigan, Inc.332 enrolled33 locationsNCT07210723
Recruiting
Not Applicable

Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions

Genetic TestingPulmonary Arterial HypertensionHeart Defects, Congenital
Universitaire Ziekenhuizen KU Leuven21 enrolled1 locationNCT02691689
Recruiting
Phase 2

Ketamine Alcohol (in Treatment-Resistant Depression)

Magnetic Resonance ImagingAlcoholismMajor Depression
Mark Niciu60 enrolled1 locationNCT02122562
Recruiting

Telegenetics or In-Person Genetic Counselling

Genetic Counselling
National Cancer Centre, Singapore150 enrolled1 locationNCT04738708
Recruiting
Phase 2Phase 3

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers

PharmacokineticsPharmacodynamicsInsulin Aspart
Amphastar Pharmaceuticals, Inc.60 enrolled1 locationNCT07560150
Recruiting
Not Applicable

I-TOPS With Patients With Genetic Syndrome SYN-TOPS

Genetic Syndrome
IRCCS Eugenio Medea42 enrolled1 locationNCT07563218
Recruiting

Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition

Genetic Predisposition
St. Jude Children's Research Hospital125 enrolled1 locationNCT05849155
Recruiting

Adaptive Optics Retinal Imaging in Inherited and Acquired Retinal Disorders

Genetic DiseaseInherited Disease
The Hospital for Sick Children200 enrolled1 locationNCT05386134
Recruiting
Not Applicable

Listener Training for Improved Intelligibility of People With Parkinson's Disease

Dysarthria, Hypokinetic
Utah State University360 enrolled2 locationsNCT06815263
Recruiting
Phase 4

COMS for Chronic Ulcers Treatment

Wound HealVenous Leg UlcerMagnetic Field Exposure
Sebastian Probst122 enrolled10 locationsNCT06528873
Recruiting
Not Applicable

Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing

Genetic Predisposition to DiseaseGenetic Predisposition
Dana-Farber Cancer Institute40 enrolled1 locationNCT05759143
Recruiting

Study on the Diagnostic Efficacy of ICL Selection and Prediction Depth Model Based on Eye Images

MyopiaPosterior Chamber Phakic Intraocular LensVault+2 more
Second Affiliated Hospital of Nanchang University326 enrolled1 locationNCT06669728